Visceral obesity and risk of high grade disease in clinical T1a renal cell carcinoma - Abstract

PURPOSE: Accurate assessment of disease characteristics is a prerequisite for treatment decision making regarding small renal masses.

In this study we evaluate the association between visceral obesity and Fuhrman grade in patients with cT1a renal cell carcinoma.

MATERIALS AND METHODS: We retrospectively collected data on 186 patients with surgically treated cT1a renal cell carcinoma. Single slice computerized tomography was used to measure the area of visceral and subcutaneous adipose tissue. Visceral obesity was calculated as the proportion of visceral adipose tissue to overall adipose tissue. Other analyzed factors included clinical characteristics (age, gender, body mass index and tumor size) and anatomical features of the tumor defined by the R.E.N.A.L. nephrometry score. The association between predictors and high grade disease (Fuhrman grade III or IV) were assessed using logistic regression analyses.

RESULTS: A total of 47 (25.3%) tumors were classified as high grade. The percentage of visceral adipose tissue was higher in male participants but did not correlate with body mass index, age or tumor size. In univariate analyses the percentage of visceral adipose tissue and tumor size were significantly associated with higher Fuhrman grade. Multivariate analysis showed that the percentage of visceral adipose tissue (OR 1.06, p = 0.0018) and tumor size (OR 1.91, p = 0.047) were independent predictors of high grade cancer. Addition of the percentage of visceral adipose tissue to a model including clinical characteristics and anatomical features of the tumor remarkably improved its discriminatory ability (p = 0.0010).

CONCLUSIONS: Increased visceral obesity was found to be strongly associated with higher Fuhrman grade in patients with cT1a renal cell carcinoma. Further studies are needed to confirm these findings and discover the underlying biological mechanism.

Written by:
Zhu Y, Wang HK, Zhang HL, Yao XD, Zhang SL, Dai B, Shen YJ, Liu XH, Zhou LP, Ye DW.   Are you the author?
Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.

Reference: J Urol. 2013 Feb;189(2):447-53.
doi: 10.1016/j.juro.2012.09.030


PubMed Abstract
PMID: 23253956

Go "Beyond the Abstract" - Read an article written by the authors for UroToday.com

UroToday.com Renal Cancer Section